| Oxidant/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis P Cameli, A Carleo, L Bergantini, C Landi, A Prasse, E Bargagli Inflammation 43, 1-7, 2020 | 70 | 2020 |
| A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls C Landi, E Bargagli, A Carleo, L Bianchi, A Gagliardi, A Prasse, MG Perari, ... PROTEOMICS–Clinical Applications 8 (11-12), 932-950, 2014 | 65 | 2014 |
| A methodological and functional proteomic approach of human follicular fluid en route for oocyte quality evaluation L Bianchi, A Gagliardi, G Campanella, C Landi, A Capaldo, A Carleo, ... Journal of proteomics 90, 61-76, 2013 | 63 | 2013 |
| Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis C Landi, E Bargagli, L Bianchi, A Gagliardi, A Carleo, D Bennett, ... Journal of proteomics 83, 60-75, 2013 | 63 | 2013 |
| BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases M d’Alessandro, A Carleo, P Cameli, L Bergantini, A Perrone, L Vietri, ... Clinical and Experimental Medicine 20, 207-216, 2020 | 60 | 2020 |
| Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers C Landi, E Bargagli, A Carleo, RM Refini, D Bennett, L Bianchi, G Cillis, ... Rheumatology 58 (1), 165-178, 2019 | 41 | 2019 |
| A functional proteomics approach to the comprehension of sarcoidosis C Landi, E Bargagli, A Carleo, L Bianchi, A Gagliardi, G Cillis, MG Perari, ... Journal of proteomics 128, 375-387, 2015 | 40 | 2015 |
| Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis A Carleo, E Bargagli, C Landi, D Bennett, L Bianchi, A Gagliardi, ... Journal of breath research 10 (2), 026007, 2016 | 34 | 2016 |
| Harnessing the role of HDAC6 in idiopathic pulmonary fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors G Campiani, C Cavella, JD Osko, M Brindisi, N Relitti, S Brogi, ... Journal of medicinal chemistry 64 (14), 9960-9988, 2021 | 30 | 2021 |
| Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation A Carleo, C Landi, A Prasse, L Bergantini, M d'Alessandro, P Cameli, ... Monaldi Archives for Chest Disease 90 (2), 2020 | 30 | 2020 |
| Common molecular pathways targeted by nintedanib in cancer and IPF: A bioinformatic study C Landi, A Carleo, L Vantaggiato, L Bergantini, M d’Alessandro, P Cameli, ... Pulmonary pharmacology & therapeutics 64, 101941, 2020 | 27 | 2020 |
| Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy C Landi, L Bergantini, P Cameli, M d’Alessandro, A Carleo, E Shaba, ... Scientific reports 10 (1), 9378, 2020 | 26 | 2020 |
| Sarcoidosis: proteomics and new perspectives for improving personalized medicine C Landi, A Carleo, G Cillis, P Rottoli Expert Review of Proteomics 15 (10), 829-835, 2018 | 26 | 2018 |
| Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? M D'alessandro, L Bergantini, A Carleo, P Cameli, A Perrone, A Fossi, ... Minerva Medica 113 (3), 526-531, 2020 | 21 | 2020 |
| What makes A. guillouiae SFC 500-1A able to co-metabolize phenol and Cr (VI)? A proteomic approach OM Ontañon, C Landi, A Carleo, A Gagliardi, L Bianchi, PS González, ... Journal of hazardous materials 354, 215-224, 2018 | 19 | 2018 |
| Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab C Landi, P Cameli, L Vantaggiato, L Bergantini, M d'Alessandro, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1869 (2), 140563, 2021 | 18 | 2021 |
| The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases. E Bargagli, P Cameli, A Carleo, RM Refini, L Bergantini, M D'alessandro, ... Panminerva Medica 62 (2), 109-115, 2019 | 14 | 2019 |
| Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency? A Carleo, J Chorostowska-Wynimko, T Koeck, H Mischak, ... International Journal of Chronic Obstructive Pulmonary Disease, 829-837, 2017 | 14 | 2017 |
| Biomarkers in sarcoidosis: the contribution of system biology A Carleo, D Bennett, P Rottoli Current Opinion in Pulmonary Medicine 22 (5), 509-514, 2016 | 14 | 2016 |
| Proteome characterization of BALF extracellular vesicles in idiopathic pulmonary fibrosis: Unveiling undercover molecular pathways E Shaba, C Landi, A Carleo, L Vantaggiato, E Paccagnini, M Gentile, ... International Journal of Molecular Sciences 22 (11), 5696, 2021 | 13 | 2021 |
Rottoli Puniversità di SienaVerified email at unisi.it
